Pharmatest will participate in ASBMR Annual Meeting 2024

  • Post published:

Pharmatest will participate in ASBMR Annual Meeting 2024 and Rare Bone Disease Symposium on Exploring and Expanding Treatments and Analytical Tools in Rare Bone Diseases, September 26-30 in Toronto!

We will present a poster “Effects of Anabolic Treatments with Teriparatide and Romosozumab on Bone in +/G610C Mouse Model of Adult Osteogenesis Imperfecta” with presentation numbers Sat-183 (ASBMR) and PM-116 (Rare Bone Diseases).

Let us know if you would like to discuss how Pharmatest could help you with your research.

ASBMR2024
rarediseases
bonediseases
CRO
preclinicalresearch